2019 annual financial data
Corbus Pharmaceuticals Holdings 2019 Operating cash flow margin
Direct answer
Operating cash flow margin was -126.5%.
Operating income was -77,104,579 USD and net income was -71,453,718 USD.
Operating cash flow was -45,720,728 USD.
Get free Corbus Pharmaceuticals Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 36,143,568 USD
- Operating income
- -77,104,579 USD
- Net income
- -71,453,718 USD
- Operating cash flow
- -45,720,728 USD